Fentanyl Trends and Forecast
The future of the global fentanyl market looks promising with opportunities in the hospital, oncology center, and surgical center markets. The global fentanyl market is expected to grow with a CAGR of 6.2% from 2024 to 2030. The major drivers for this market are rising aging population globally, increasing incidences of cancer and rising oncology spending.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Fentanyl by Segment
The study includes a forecast for the global fentanyl by route of administration, end use, and region.
Fentanyl Market by Route of Administration [Shipment Analysis by Value from 2018 to 2030]:
• Sublingual Tablet
• Buccal Tablet
• Oral Film
• Others
Fentanyl Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospital
• Oncology Centers
• Surgical Centers
• Others
Fentanyl Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Fentanyl Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fentanyl companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fentanyl companies profiled in this report include-
• Bayer
• Novartis
• Sanofi-aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries
Fentanyl Market Insights
Lucintel forecasts that oral film is expected to witness the highest growth over the forecast period.
Within this market, oncology center will remain the largest segment due to rising number of individuals diagnosed with cancer.
North America is expected to witness highest growth over the forecast period due to increasing population and research endeavors, coupled with health insurance encompassing diverse cancer diagnoses.
Features of the Global Fentanyl Market
Market Size Estimates: Fentanyl market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Fentanyl market size by route of administration, end use, and region in terms of value ($B).
Regional Analysis: Fentanyl market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different route of administration, end use, and regions for the fentanyl market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fentanyl market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for fentanyl market?
Answer: The global fentanyl market is expected to grow with a CAGR of 6.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the fentanyl market?
Answer: The major drivers for this market are rising aging population globally, increasing incidences of cancer and rising oncology spending.
Q3. What are the major segments for fentanyl market?
Answer: The future of the global fentanyl market looks promising with opportunities in the hospital, oncology center, and surgical center markets.
Q4. Who are the key fentanyl market companies?
Answer: Some of the key fentanyl companies are as follows:
• Bayer
• Novartis
• Sanofi-aventis Groupe
• Abbott Laboratories
• Merck & Co
• Validus Pharmaceuticals
• Teva Pharmaceutical Industries
Q5. Which fentanyl market segment will be the largest in future?
Answer: Lucintel forecasts that oral film is expected to witness the highest growth over the forecast period.
Q6. In fentanyl market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to increasing population and research endeavors, coupled with health insurance encompassing diverse cancer diagnoses.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the fentanyl market by route of administration (sublingual tablet, buccal tablet, oral film, and others ), end use (hospital, oncology centers, surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Fentanyl Market, Fentanyl Market Size, Fentanyl Market Growth, Fentanyl Market Analysis, Fentanyl Market Report, Fentanyl Market Share, Fentanyl Market Trends, Fentanyl Market Forecast, Fentanyl Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.